Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bordetella pertussis is a Gram-negative bacterium that is the causative agent of whooping cough (pertussis). It colonizes the ciliated epithelial cells of the respiratory tract and produces various virulence factors, including pertussis toxin, adenylate cyclase toxin, filamentous hemagglutinin, pertactin, and fimbriae, which contribute to disease pathogenesis. Humans are the only known reservoir for this pathogen. Whole-cell preparations have been used in vaccines.
Antibiotics inhibit bacterial growth and survival. Vaccines stimulate an immune response to prevent infection.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella pertussis (whole-cell) (B. pertussis).